Want to see GB:SPEC full AI Analyst Report?
Top Page
Inspecs Group Plc
(LSE:SPEC)
Select Model
Select Model
Rating:45Neutral
Price Target:
94.00 p
▼(-3.09% Downside)
Action:Reiterated
Date:08/21/26
The score is held down primarily by weak financial performance—ongoing net losses, a sharp 2025 revenue decline, and a swing to negative free cash flow. Technicals provide only modest support (positive MACD but weak RSI), while valuation is also constrained by negative earnings and the absence of a dividend yield.
Positive Factors
Manageable Leverage
Moderate leverage gives Inspecs some financial flexibility and reduces immediate balance-sheet strain. This can support continued investment in its integrated eyewear platform, although persistent losses could weaken that cushion over time.
Negative Factors
Sharp Revenue Decline
The consecutive revenue declines suggest weakening demand, customer orders or market execution rather than a one-period fluctuation. Sustained top-line pressure can reduce purchasing leverage, limit fixed-cost absorption and make a return to profitability more difficult.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable Leverage
Moderate leverage gives Inspecs some financial flexibility and reduces immediate balance-sheet strain. This can support continued investment in its integrated eyewear platform, although persistent losses could weaken that cushion over time.
Read all positive factors
Inspecs Group Plc (SPEC) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£104.81M
Dividend YieldN/A
Average Volume (3M)117.09K
Price to Earnings (P/E)―
Beta (1Y)0.43
Revenue Growth-3.31%
EPS Growth-107.51%
CountryUK
Employees1,656
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.07
Shares Outstanding109,174,520
10 Day Avg. Volume109,092
30 Day Avg. Volume117,088
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)1.23
Price to Sales (P/S)0.51
P/FCF Ratio-43.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.07
Revenue Forecast (FY)£196.00M
Inspecs Group Plc Business Overview & Revenue Model
Company Description
INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufac...
How the Company Makes Money
Inspecs Group makes money primarily by selling eyewear products—most notably optical frames and related eyewear components—to business customers such as optical retailers, distributors, and other eyewear companies. Its revenue model is largely who...
Inspecs Group Plc Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
57
Neutral
Cash Flow
31
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 191.70M | 198.26M | 203.29M | 200.96M | 182.62M |
| Gross Profit | 87.37M | 103.45M | 103.55M | 98.86M | 85.78M |
| EBITDA | 17.49M | 15.75M | 17.27M | 8.28M | 6.05M |
| Net Income | -6.51M | -4.61M | -997.00K | -6.32M | ― |
Balance Sheet | |||||
| Total Assets | 202.23M | 220.25M | 221.91M | 292.68M | 326.36M |
| Cash, Cash Equivalents and Short-Term Investments | 15.99M | 23.96M | 20.07M | 26.80M | 29.76M |
| Total Debt | 59.78M | 62.47M | 62.12M | 69.78M | 69.44M |
| Total Liabilities | 122.51M | 121.56M | 118.39M | 162.59M | 181.13M |
| Stockholders Equity | 79.72M | 98.69M | 103.52M | 130.09M | 145.22M |
Cash Flow | |||||
| Free Cash Flow | -2.26M | 4.28M | 6.92M | 842.00K | 12.37M |
| Operating Cash Flow | 93.00K | 7.20M | 12.66M | 5.08M | 19.75M |
| Investing Cash Flow | -2.65M | -2.52M | -6.18M | -4.19M | -15.66M |
| Financing Cash Flow | -4.85M | -426.00K | -8.84M | -4.40M | 1.26M |
Inspecs Group Plc Technical Analysis
Neutral
97.00
Price Trends
96.76
Negative
90.72
Positive
83.22
Positive
Market Momentum
-0.02
Positive
39.41
Neutral
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SPEC, the sentiment is Neutral. The current price of 97 is above the 20-day moving average (MA) of 96.65, above the 50-day MA of 96.76, and above the 200-day MA of 83.22, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 39.41 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:SPEC.
Inspecs Group Plc Peers Comparison
UnderperformOutperform
Sector (51)
GB:SPEC
Inspecs Group Plc
96.00
52.00
118.18%
GB:CVSG
CVS Group plc
1,322.00
124.34
10.38%
Inspecs Group Plc Corporate Events
Business Operations and StrategyExecutive/Board ChangesM&A Transactions
Inspecs Board Change Follows Completion of Bidco Takeover
Neutral
Jul 31, 2026
Inspecs Group plc, a global eyewear solutions provider with a vertically integrated business model, produces branded and OEM optical frames, sunglasses, safety eyewear and low vision aids for retailers and opticians worldwide. The Group’s ex...
Business Operations and StrategyExecutive/Board Changes
Inspecs appoints new CFO to steer next phase of global eyewear growth
Positive
Jul 16, 2026
Inspecs Group plc has appointed Robert Brodie as its new Chief Financial Officer, with plans for him to join in autumn 2026 and take a seat on the board as an executive director, succeeding Chris Kay, who will remain as a consultant to ensure a sm...
Business Operations and StrategyShareholder Meetings
Inspecs shareholders back ordinary AGM resolutions but reject specials
Neutral
Jun 30, 2026
Inspecs Group plc, a leading global eyewear designer and manufacturer, produces branded and private-label optical frames, sunglasses, safety eyewear and low vision products, supported by vertically integrated operations across Europe, Asia and the...
Business Operations and StrategyPrivate Placements and Financing
Inspecs secures Qualcomm investment and smart eyewear partnership
Positive
Jun 16, 2026
Inspecs Group has secured a $10m (£7.5m) strategic equity investment from Qualcomm Technologies via a subscription for 7.5m new shares at £1 each, with the funds earmarked to support growth and general working capital. The move modestly ...
Financial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Inspecs Publishes Annual Report and Sets Date for 2026 AGM
Neutral
Jun 8, 2026
Inspecs Group plc has posted its latest Annual Report and Accounts and the notice of its upcoming Annual General Meeting, making these documents available to shareholders on its website. The AGM is scheduled to take place on 30 June 2026 at 11:00 ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.